110 results
6-K
EX-99.1
BLRX
Bioline Rx Ltd
17 Apr 24
BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4
7:12am
cause suboptimal experiences for patients, as well as delays in care and cost impact,” said Edmund K. Waller, MD, PhD, FACP, Department of Hematology … with CXCR4 Antagonists: Evidence from the Phase 3 Trials
Authors: Edmund K. Waller, MD, PhD, FACP, Department of Hematology and Medical Oncology, Winship
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
(kk) U.S. Real Property Holding Corporation
6-K
EX-10.2
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
, an unincorporated organization, any other entity and a government or any department or agency thereof.
(r) “Principal Market” means The Nasdaq Capital
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
was head of the SEC and U.S. Accounting Department at the National Office in Tel Aviv, as well as seven years at the SEC at its Washington, D.C … postdoctoral training at Yale Medical School in the department of pathology.
Raphael Hofstein, Ph.D., has served on our board of directors since 2003, our
6-K
666652e5 tt
12 Dec 23
Current report (foreign)
7:07am
6-K
EX-99
ma900
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
fhasmh6ca7k0ax
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
ghmmlczqod3jqghpgi
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
6-K
EX-10.1
j5jfcgnbjs8m
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-99
44q5f3x8qvq6
15 Sep 22
Current report (foreign)
8:39am
6-K
EX-99
11jtnr88
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-99
mk4 ftknfojd3
15 Dec 21
BioLineRx Announces Formation of Immuno-Oncology
7:25am
6-K
EX-99
sksexkcx
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
EX-10.1
3xbqg5xj9sxb v1
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-99
xrne0hvbq0ll
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm